- Home
- HRI vs RNA Comparison
HRI vs RNA Comparison
Compare HRI & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRI
- RNA
- Stock Information
- Founded
- HRI 1965
- RNA 2012
- Country
- HRI United States
- RNA United States
- Employees
- HRI N/A
- RNA N/A
- Industry
- HRI Misc Corporate Leasing Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- HRI Industrials
- RNA Health Care
- Exchange
- HRI Nasdaq
- RNA Nasdaq
- Market Cap
- HRI 4.2B
- RNA 4.0B
- IPO Year
- HRI N/A
- RNA 2020
- Fundamental
- Price
- HRI $127.68
- RNA $40.06
- Analyst Decision
- HRI Buy
- RNA Strong Buy
- Analyst Count
- HRI 5
- RNA 16
- Target Price
- HRI $144.60
- RNA $69.81
- AVG Volume (30 Days)
- HRI 408.7K
- RNA 3.7M
- Earning Date
- HRI 10-21-2025
- RNA 11-06-2025
- Dividend Yield
- HRI 2.18%
- RNA N/A
- EPS Growth
- HRI N/A
- RNA N/A
- EPS
- HRI 0.79
- RNA N/A
- Revenue
- HRI $3,779,000,000.00
- RNA $10,729,000.00
- Revenue This Year
- HRI $25.22
- RNA N/A
- Revenue Next Year
- HRI $14.28
- RNA $109.60
- P/E Ratio
- HRI $162.21
- RNA N/A
- Revenue Growth
- HRI 11.41
- RNA 1.23
- 52 Week Low
- HRI $96.19
- RNA $21.51
- 52 Week High
- HRI $246.88
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- HRI 48.28
- RNA 41.60
- Support Level
- HRI $124.83
- RNA $39.83
- Resistance Level
- HRI $139.70
- RNA $46.23
- Average True Range (ATR)
- HRI 6.13
- RNA 2.92
- MACD
- HRI -0.39
- RNA -1.24
- Stochastic Oscillator
- HRI 20.45
- RNA 27.77
About HRI Herc Holdings Inc.
Herc Holdings is an equipment rental company that was spun out of Hertz Global in 2016. It is the third-largest player in North America, after United Rentals and Sunbelt Rentals, with an approximate 6% market share pro forma for its 2025 acquisition of H&E Equipment Services. It serves a similar mix of companies to its peers (industrial, commercial, and residential construction) from its 450 locations targeting the top 100 metropolitan markets in the US. Herc's rental fleet of approximately $7 billion is also similar in composition to its peer group in terms of equipment offered. The company is pursuing diversification by bundling and increasing specialty solutions for its customer base. Herc's portfolio skews toward local customers versus national accounts (60/40).
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.